BioCentury | Apr 6, 2019
Finance

Everybody up

...Rocklatan netarsudil/latanoprost to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Aeterna Zentaris...
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Strongbridge Biopharma plc (NASDAQ:SBBP) licensed U.S. and Canadian rights to Macrilen macimorelin acetate from Aeterna Zentaris...
...U.S. $175.0 Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Rhopressa netasurdil Glaucoma or ocular hypertension U.S. $9.7 Aeterna Zentaris...
BioCentury | Nov 30, 2018
Clinical News

CHMP backs first all-oral sleeping sickness treatment, extensions for Blincyto, Opdivo-Yervoy combo

...CHMP also recommended Macrilen macimorelin acetate, an oral ghrelin-mimetic growth hormone secretagogue from Aeterna Zentaris...
...other trials of Tecentriq as a monotherapy or as part of a combination therapy. Aeterna Zentaris...
...Compound #), apalutamide (Generic), Erleada (Other) Fexinidazole Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Opdivo/Yervoy, nivolumab/ipilimumab Aeterna Zentaris...
BioCentury | Nov 16, 2018
Company News

CHMP backs first all-oral sleeping sickness treatment, extensions for Blincyto, Opdivo-Yervoy combo

...CHMP also recommended Macrilen macimorelin acetate, an oral ghrelin-mimetic growth hormone secretagogue from Aeterna Zentaris...
...Compound #), apalutamide (Generic), Erleada (Other) Fexinidazole Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Opdivo/Yervoy, nivolumab/ipilimumab Aeterna Zentaris...
BioCentury | Nov 2, 2018
Company News

Strongbridge hands off Macrilen to Novo for sizable return

...gained $2.35 (58%) to $6.40 on Oct. 31. Strongbridge doled out $24 million to Aeterna Zentaris...
...sales. The company did not respond to inquiries. Strongbridge Biopharma plc (NASDAQ:SBBP), Trevose, Pa. Aeterna Zentaris...
...Bagsvaerd, Denmark Business: Endocrine, Diagnostic Elizabeth S. Eaton Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Aeterna Zentaris...
BioCentury | Oct 31, 2018
Company News

Strongbridge hands off Macrilen to Novo for sizable return

...Strongbridge gained $2.35 (58%) to $6.40 on Wednesday. Strongbridge doled out $24 million to Aeterna Zentaris...
...did not respond to inquiries. Elizabeth S. Eaton Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Aeterna Zentaris...
BioCentury | Jul 10, 2018
Distillery Therapeutics

Cancer

...treat solid tumors with KRAS (K-Ras), BRAF or neuroblastoma Ras viral oncogene (NRAS) mutations. Aeterna Zentaris...
BioCentury | Jul 6, 2018
Company News

Management tracks: Goldman Sachs, Acceleron

...Switzerland) hired Richard Sachse as global CSO. He was SVP, CSO and CMO at Aeterna Zentaris...
BioCentury | May 23, 2018
Distillery Techniques

Disease models

...with vehicle. Next steps could include using the model to screen other PCOS therapies. Aeterna Zentaris...
BioCentury | Jan 9, 2018
Finance

Stars in China

...0.02% to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension Aeterna Zentaris...
Items per page:
1 - 10 of 456
BioCentury | Apr 6, 2019
Finance

Everybody up

...Rocklatan netarsudil/latanoprost to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Aeterna Zentaris...
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Strongbridge Biopharma plc (NASDAQ:SBBP) licensed U.S. and Canadian rights to Macrilen macimorelin acetate from Aeterna Zentaris...
...U.S. $175.0 Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Rhopressa netasurdil Glaucoma or ocular hypertension U.S. $9.7 Aeterna Zentaris...
BioCentury | Nov 30, 2018
Clinical News

CHMP backs first all-oral sleeping sickness treatment, extensions for Blincyto, Opdivo-Yervoy combo

...CHMP also recommended Macrilen macimorelin acetate, an oral ghrelin-mimetic growth hormone secretagogue from Aeterna Zentaris...
...other trials of Tecentriq as a monotherapy or as part of a combination therapy. Aeterna Zentaris...
...Compound #), apalutamide (Generic), Erleada (Other) Fexinidazole Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Opdivo/Yervoy, nivolumab/ipilimumab Aeterna Zentaris...
BioCentury | Nov 16, 2018
Company News

CHMP backs first all-oral sleeping sickness treatment, extensions for Blincyto, Opdivo-Yervoy combo

...CHMP also recommended Macrilen macimorelin acetate, an oral ghrelin-mimetic growth hormone secretagogue from Aeterna Zentaris...
...Compound #), apalutamide (Generic), Erleada (Other) Fexinidazole Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Opdivo/Yervoy, nivolumab/ipilimumab Aeterna Zentaris...
BioCentury | Nov 2, 2018
Company News

Strongbridge hands off Macrilen to Novo for sizable return

...gained $2.35 (58%) to $6.40 on Oct. 31. Strongbridge doled out $24 million to Aeterna Zentaris...
...sales. The company did not respond to inquiries. Strongbridge Biopharma plc (NASDAQ:SBBP), Trevose, Pa. Aeterna Zentaris...
...Bagsvaerd, Denmark Business: Endocrine, Diagnostic Elizabeth S. Eaton Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Aeterna Zentaris...
BioCentury | Oct 31, 2018
Company News

Strongbridge hands off Macrilen to Novo for sizable return

...Strongbridge gained $2.35 (58%) to $6.40 on Wednesday. Strongbridge doled out $24 million to Aeterna Zentaris...
...did not respond to inquiries. Elizabeth S. Eaton Macrilen, macimorelin acetate (AEZS-130, ard-07, macrimorelin-ghst, EP01572, EP-1572, Solorel) Aeterna Zentaris...
BioCentury | Jul 10, 2018
Distillery Therapeutics

Cancer

...treat solid tumors with KRAS (K-Ras), BRAF or neuroblastoma Ras viral oncogene (NRAS) mutations. Aeterna Zentaris...
BioCentury | Jul 6, 2018
Company News

Management tracks: Goldman Sachs, Acceleron

...Switzerland) hired Richard Sachse as global CSO. He was SVP, CSO and CMO at Aeterna Zentaris...
BioCentury | May 23, 2018
Distillery Techniques

Disease models

...with vehicle. Next steps could include using the model to screen other PCOS therapies. Aeterna Zentaris...
BioCentury | Jan 9, 2018
Finance

Stars in China

...0.02% to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension Aeterna Zentaris...
Items per page:
1 - 10 of 456